CEDARVILLE, OHIO, Dec. 11, 2017 -- Collaborative research by Cedarville senior biomedical engineers and the school of pharmacy shows that 3D printing of human tissue scaffolds has tremendous potential for regrowing bone. Their research will be published by the Orthopedic Research Society (ORS) in March 2018.
3D printing is commonly associated with the industrial design field, where printers are used to create prototypes or actual parts for cars, planes and machinery or scale architectural and other types of models. Now 3D printing is being employed to recreate human organs and bone-building scaffolds.
The biomedical engineering students working on this project are seniors Mitchell Ryan (Hopkins, Michigan), Daniel Sidle (Macedonia, Ohio), Stephan Smith (Prompton Plains, New Jersey), Jacob Cole (Sidney, Maine), Tierra Martinelli (Cincinnati, Ohio) and freshman Sarah Seman (Delmont, Pennsylvania).
According to Dr. Tim Norman, professor of mechanical and biomedical engineering, biomedical engineering and pharmacy students are producing a scaffold, which is like a frame for bone tissue cells to grow, using a 3D printer. PLA (polylactic acid) is used in the printer; it is a biocompatible and biodegradable substance. The scaffold is a framework with which the cells will easily inhabit and mimics the body tissue being regrown.
The scaffold is submerged into a liquid growth media full of normal endothelial cells that will attach to the scaffold and reproduce. The biomedical engineering design group is partnering with Dr. Rocco Rotello, associate professor of pharmaceutical sciences, to culture human cells in the pharmaceutical science laboratory.
Ideally, the cell-enriched scaffold would be implanted into the body to eventually regrow the missing tissue. The scaffold is resorbed by the patient’s body, while the cells produce the new tissue.
“The biomedical field is growing and moving so quickly, and this project reveals the interdisciplinary nature of this field extremely well,” Norman said. “It shows our students that collaborative work with other disciplines is necessary for successful biomedical engineering projects.”
Cedarville began this research in 2015 and is still in the early stages of the research process. The biomedical engineering department’s research paper about the material properties of 3D printed scaffolds will be published in March 2018 at the ORS annual meeting in New Orleans.
The end goal of this research is to design a scaffold that supports cell life and represents the tissue it is meant to replace.
Located in southwest Ohio, Cedarville University is an accredited, Christ-centered, Baptist institution with an enrollment of 3,963 undergraduate, graduate, and online students in more than 150 areas of study. Founded in 1887, Cedarville is recognized nationally for its authentic Christian community, rigorous academic programs, strong graduation and retention rates, accredited professional and health science offerings, and leading student satisfaction ratings. For more information about the University, visit www.cedarville.edu.
|
||||||||
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6e3db6cd-ce66-43bb-8051-ca47002f12d1
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/19f26b28-7e79-4c4e-bf82-85cd25acd58d
Mark D. Weinstein Cedarville University 937-766-8800 [email protected]


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Anta Sports Expands Global Footprint With Strategic Puma Stake
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



